Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6585 record(s)

Req # A-2019-001710

Adverse Reaction Report (AER) for ALUNBRIG. Report number: ALUNBRIG: E2B_02779985.

Organization: Health Canada

10 page(s)
February 2020

Req # A-2019-001723

Adverse Reaction Report (AER) for Mezavant. Report numbers: 000728451, 000729354, 000729436.

Organization: Health Canada

7 page(s)
February 2020

Req # A-2019-001727

Adverse Reaction Report (AER) for GAMMAGARD LIQUID. Report numbers: 000728962, 000728969, 000729342, 000729853, 000729855, 000728875, 000728906, 000728944, 000728949, 000730606, 000730608, 000730645, E2B_02786597, E2B_02790769, E2B_02791427.

Organization: Health Canada

65 page(s)
February 2020

Req # A-2019-001728

Adverse Reaction Report (AER) for GAMMAGARD S/D. Report numbers: 000730130, E2B_02747530, E2B_02747562.

Organization: Health Canada

59 page(s)
February 2020

Req # A-2019-001731

Adverse Reaction Report (AER) for BRIGATINIB. Report number: E2B_02781765.

Organization: Health Canada

13 page(s)
February 2020

Req # A-2019-001737

Adverse Reaction Report (AER) for PANTOLOC. Report numbers: E2B_02774280, E2B_02774302, E2B_02772419, E2B_02772402, E2B_02774439.

Organization: Health Canada

79 page(s)
February 2020

Req # A-2019-001744

Adverse Reaction Report (AER). Report number: E2B_02552133.

Organization: Health Canada

6 page(s)
February 2020

Req # A-2019-001753

Adverse Reaction Report (AER) for INSULIN GLARGINE. Report numbers: 722608, 724576.

Organization: Health Canada

6 page(s)
February 2020

Req # A-2019-001756

Adverse Reaction Report (AER) for TERIFLUNOMIDE. Report number: 723265.

Organization: Health Canada

2 page(s)
February 2020

Req # A-2019-001800

Adverse Reaction Report (AER) for POLYSPORIN. Report numbers: 000003047, 000014656, 000144085, 000319887, 000430437, 000661650, 000697934, 000708285. AER for IMODIUM / LOPERAMIDE HCI. Report numbers: 000698619, 000166886,000223788, 000373375, 000680312, 000688067, 000689740, 000727463. AER for ROGAINE. Report numbers: 000058921, 000070668, 000078274, 000154562, 000700961, 000709320, 000718463. AER for MOTRIMAX. Report numbers: 000671220, 000680949, 000715106.

Organization: Health Canada

109 page(s)
February 2020
Date modified: